AstraZeneca and GSK settle talent feud in court — again
AstraZeneca and GSK have settled their latest talent skirmish, clearing the way for 18-plus-year AstraZeneca veteran Chris Sheldon to start a new gig at the rival pharma next month.
Sheldon and GSK confirmed the news to Endpoints News on Tuesday, more than a month after AstraZeneca was granted an injunction to stop him from starting at GSK as the next senior VP of its commercial portfolio, multiple sources including the Financial Times reported in August.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.